Why Our AI Engine Matters

End-To-End Process

From AI design to targeted RNA degradation

Scientific Validation

97.1% Efficiency Reducing Cell Mortality

  • 5 Human Cell Types
  • p = 0.0007
  • No Significant Toxicity Observed

Key Advantages Of The Platform

Initial Program-Antiviral pipeline

Significant Milestones

Market Opportunity

Viritis Main Team

Built by Experts in AI, Therapeutics & Drug Development

Be a part of the future of therapeutics